Single nucleotide polymorphisms modify the transporter activity of ABCG2. - Wikidata - wikimedia - TriplyDB

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

http://www.wikidata.org/entity/Q33214177

about

Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.ABCG2: the molecular mechanisms of urate secretion and gout Expression levels of the ABCG2 multidrug transporter in human erythrocytes correspond to pharmacologically relevant genetic variations Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter Membrane transporters in drug development Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer.ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytes.Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter.Key Role of Human ABC Transporter ABCG2 in Photodynamic Therapy and Photodynamic Diagnosis.The pharmacogenetics of imanitib.Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.ABC multidrug transporters: structure, function and role in chemoresistance.The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins.Genetic variation: effect on prostate cancer.The challenge of exploiting ABCG2 in the clinic.ABCG2: a perspective.Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme.In Vitro Screening of Environmental Chemicals Identifies Zearalenone as a Novel Substrate of the Placental BCRP/ABCG2 Transporter.Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance.A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications.Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter Antiepileptic medication during pregnancy: does fetal genotype affect outcome?Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant.ABCG transporters and disease.ABCG2 in peptic ulcer: gene expression and mutation analysis Cancer stem cells in breast: current opinion and future challenges.Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.Association of single nucleotide polymorphisms in MTHFR and ABCG2 with the different efficacy of first-line chemotherapy in metastatic colorectal cancer.

P2860

Q27851688-07E7169D-53EF-4BE4-9B3B-7DB069396E4F Q28087044-2805ACB8-F39E-42B3-ADCB-3D3CCEE63D4D Q28485221-9AEDBB30-7AB9-483C-B78F-0D20C7109CC6 Q28552715-68E333DB-65B0-4B96-9516-19357DCDD399 Q29616802-E6509822-AA10-4D9D-898C-874C61D271B2 Q33418358-54D0C070-D017-4B79-96C0-5EDAF8575953 Q33602553-BE357BA0-4F29-4535-9E30-F3C7CA0B6F5F Q33714593-024D23FE-FA6A-4FA8-AED2-269F73F1250B Q33776950-3EF3C921-F425-462C-853D-F576D4DBCE06 Q33834417-576A5098-C808-4C18-B1FB-603771AFBBDE Q34008793-3B947493-9F03-4940-B7CC-070D8E242087 Q34035243-0EA5AC16-582D-444E-A6F8-589992BF599A Q34176588-985B24B8-3A96-4199-8543-151C24EA54E0 Q34179757-DEC17B93-BE64-4362-8881-F50399492397 Q34415050-F3A01AED-D5B1-4085-8FB5-6344561DA30F Q34469295-40DD2EB4-E7FB-4E1E-B6C7-E4AC7E67FDF1 Q34568808-ADA642E8-2CEE-47A4-9EFF-40B2BDD5F725 Q34586418-6E8F8038-789A-48F6-B415-55EDE6E7777B Q34631971-56F3ED81-D4C2-4B5D-93F0-FB28833F5948 Q34663656-5A6EDD71-DD4C-4C2E-900A-727EC01319DF Q34968909-83AAEC12-0070-415F-8C36-0E493729DE60 Q35016817-4C5A14C7-B7A9-4A95-B4E1-FA584F323EF4 Q35079153-D65531BE-F680-4C07-B9BB-4B2E57428E7C Q35655939-93E8B5B7-3EA6-4009-B15D-B907EF98CFB6 Q35775875-72847259-E9F6-4171-9B7F-F073B6D4B591 Q35946822-FAC59189-F642-4E1D-ABA4-C22D385EB9A1 Q36204229-FF46001D-7834-495A-8BDC-056D4ACB9A78 Q36301589-7C67F9A0-4819-474B-9AED-0FE3D6176133 Q36729796-B5A6FE4C-5D2A-433E-9857-2446B7FB6DA7 Q36733503-867B0AD2-F109-4E9B-85C3-22A694E89F64 Q36863422-525D1C3A-9FCA-4F54-9C1F-B0394071A768 Q36923104-209C0C02-0BDF-43BF-972D-3C7A9760F824 Q37020542-89585427-4B71-4286-B7DC-1B08A6795EE4 Q37074550-5939E1EF-7A3F-4CD9-B327-7939FC8FD055 Q37099947-953D9557-3BE2-4774-9630-F843A94C1601 Q37131899-E9652F32-07CD-4F65-A276-74FE2A5CC92C Q37188273-1CBB2E0B-E914-46D4-903A-66A1BBB24B2D Q37219909-8A9406A9-F972-44F0-9768-92AC18145771 Q37415822-A89F19F4-2D2D-4269-B0FE-85575BA0DDCA Q37471631-D2CA9FB9-77BE-4996-B306-91266606CAD2

P2860

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

http://www.wikidata.org/entity/Q33214177

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

@ast

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

@en

type

label

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

@ast

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

@en

prefLabel

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

@ast

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

@en

P1433

Q33214177-CBCF5884-3271-48DB-9EBB-94813314587E

P1476

Q33214177-0E6463E9-4845-4C8A-AEBD-23AE412CDE5F

P2093

Q33214177-4630FF86-4653-4C50-950E-23CF1FF0B66A

Q33214177-7C4E8D02-59BC-4CBD-9489-1C31FD4617C6

Q33214177-8A1B134D-D483-4ABD-BFEE-0F81C95838CD

Q33214177-8D40D2FF-44F6-42F5-89DB-C0CAD124ABC8

Q33214177-917B3512-A55F-46C6-8289-7156F58AE9D9

Q33214177-DAC6A389-C1B6-4019-9A8E-EF2180A9D338

Q33214177-F61D13CF-83DE-453A-8CAE-8FE15B0D7201

Q33214177-FF1E626C-40B0-40A7-9B84-4FC972D14BCE

P2888

Q33214177-6E53D718-8B9E-437D-83DE-8D0A0A79D223

P304

Q33214177-9D141ACC-DECE-4BAE-8101-C42ACABFBFAE

P31

Q33214177-8B168261-C324-4AC9-8DA4-0D96FCFC7D83

P356

Q33214177-9E21274E-BE0E-41B0-B5BC-BCEED9807C8F

P433

Q33214177-3410C85F-E10E-466D-9DDE-F9D5122DC089

P478

Q33214177-4F51F0E9-B9E1-4114-A10D-0CAB158DA23D

P577

Q33214177-AEEB0EAF-F71A-4173-989A-7215502F33C0

P6179

Q33214177-B24E7F04-714C-4958-B008-7CDBC99FE834

P698

Q33214177-9A9E5B20-04C4-43F9-A888-9A93B54C01EB

P921

Q33214177-BAB02577-EFC5-45DF-A855-175839E647E1

P356

S00280-004-0931-X

P1433

Cancer Chemotherapy and Pharmacology

P1476

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

@en

P2093

Balázs Sarkadi

http://www.w3.org/2001/XMLSchema#string

Csilla Ozvegy-Laczka

http://www.w3.org/2001/XMLSchema#string

Kenneth Steadman

http://www.w3.org/2001/XMLSchema#string

Kuniaki Morisaki

http://www.w3.org/2001/XMLSchema#string

Orsolya Polgar

http://www.w3.org/2001/XMLSchema#string

Robert W Robey

http://www.w3.org/2001/XMLSchema#string

Susan E Bates

http://www.w3.org/2001/XMLSchema#string

Yasumasa Honjo

http://www.w3.org/2001/XMLSchema#string

P2888

s00280-004-0931-x

P304

161-172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-004-0931-X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000696676

http://www.w3.org/2001/XMLSchema#string

P698

15838659

http://www.w3.org/2001/XMLSchema#string

P921

single-nucleotide polymorphism